[Gingival hyperplasia associated with amlodipine].

Abstract

Drug-induced gingival hyperplasia is a well documented unwanted side effect within the literature. It has been associated with the use of three different types of pharmaceutical agents, including phenytoin, cyclosporine and calcium channel blocking agents. Amlodipine belongs to the dihydropyridine-derived calcium blocking agents that may cause the side effect of drug-induced gingival hyperplasia. In the present study the possible pathogenic mechanisms, clinical and histologic presentation and therapeutic indications of amlodipine-induced gingival hyperplasia are discussed.

• Authors: P Infante Cossío, J Torelló Iserte, F Espín Gálvez, A García-Perla, L Rodríguez-Armijo Sánchez, J R Castillo Ferrando
• Journal: Anales de medicina interna (Madrid, Spain : 1984) (An Med Interna) Vol. 14 Issue 2 Pg. 83-5 (Feb 1997) ISSN: 0212-7199 [Print] Spain
• Vernacular Title: Hiperplasia gingival asociada a amlodipino.
• PMID: 9206519 (Publication Type: Case Reports, English Abstract, Journal Article)

Chemical References

• Calcium Channel Blockers
• Amlodipine

Topics

• Aged
• Amlodipine (adverse effects)
• Calcium Channel Blockers (adverse effects)
• Female
• Gingival Hyperplasia (chemically induced)
• Humans